PAX7 target gene repression was indistinguishable as a biomarker from the three based on DUX4 target gene expression (DeLong’s test P > 0.05), in line with our previous findings on RNA-Seq data from FSHD biopsies (28). Here, PAX7 is linked to facioscapulohumeral muscular dystrophy.